Abstract: An electric vehicle may include a frame, wheel assemblies, an electric motor, a rechargeable battery, and a battery compartment in which the rechargeable battery is secured to the vehicle. The electric motor may be supported by and/or coupled to the unitized frame. The electric motor may be coupled to at least one of the wheel assemblies. The rechargeable battery may be electrically coupled to the electric motor and power the electric motor. The rechargeable battery may be housed by and/or within the battery compartment. The battery compartment may be disposed above the frame and along a longitudinal centerline of the vehicle. The battery compartment may have a length of one-third or more of the longitudinal length of the frame. The length of the battery compartment may be more than three times a width of the battery compartment.

Abstract: A system for distinguishing a type of excreta deposited in a toilet is disclosed. The system includes a toilet and a processor. The toilet has a bowl adapted to receive multiple types of excreta from a user and a sensor which monitors the volume of excreta deposited in the toilet. The processor compares excreta volume data derived from the sensor to a database comprising excreta-type volume data and associates a time segment from the excreta volume data as representing an excreta-type. This system can provide data which may be used to determine the rate of excreta deposit into the toilet and associated those rates with excreta events types such as urination or defecation.

Abstract: We disclose an in-toilet urinalysis system which includes a system for collection urine and for analysis of urine components using aptamer technology. Urine collection system may dispense urine into cuvettes, channels, or other containers that include aptamers. The aptamers may detect target molecules in urine. The aptamers may measure urine analytes, detect excreted drugs or drug metabolites, or disease markers. Upon binding to the target molecule, the aptamers may produce a signal which a sensor in the toilet may detect. In some embodiments, the signal may be electrochemical, fluorescent, or colorimetric. The measurements obtained from analysis of the urine may be used to assess a user's health or diagnose disease. In some embodiments, the measurements are stored in a controller which may transmit the measurements to a healthcare provider for assessment.

Abstract: An electric vehicle may include a battery, a drive axle, a drive wheel coupled to the drive axle, and a combined motor and brake unit. The combined motor and brake unit may be electrically coupled to the battery and mechanically coupled to the drive axle. The combined motor and brake unit may include a housing, an electric motor inside the housing and electrically coupled to the battery, a transmission inside the housing, a motor output shaft, a braking mechanism, and a motor input shaft. The transmission may transmit rotation of the electric motor to the drive axle and the drive wheel. The motor output shaft may couple the electric motor to the transmission. The braking mechanism may be coupled to the housing. The motor input shaft may couple the electric motor to the braking mechanism and input, to the electric motor, a braking force applied by the braking mechanism.

Abstract: An electric vehicle may include a battery module, a heat transfer circuit, and a ventilation system. The heat transfer circuit may include a first heat exchanger, a second heat exchanger, and a reversing valve. The first heat exchanger may be adjacent to the battery module and/or in thermal contact with the battery module. The second heat exchanger may exchange heat with an environment external to a cabin of the vehicle. The reversing valve may reverse a fluid flow direction of the heat transfer circuit. The ventilation system may force air across the first heat exchanger or the second heat exchanger and direct the air into the cabin of the vehicle.

Abstract: A toilet for measuring excreta is disclosed. The toilet is adapted to measure the amount of excreta received by the bowl and then the flush water. A pressure sensor is configured to monitor the pressure exerted by the flush water and any excreta contained therein. Data from monitoring the pressure of the flush water and excreta therein is used to determine the weight or volume of the excreta received by the bowl. This toilet can provide data which may be used to analyze how the volume of flush water changed due to excreta deposit. A volume change feature can be associated with a urination event and the data associated with the event can be used to determine a urine characteristic of the event.

Abstract: An analytical toilet comprising a bowl for receiving excreta from a user, a urine collection chamber in fluid communication with the bowl, a sensor for detecting properties of the urine after at least partial settling of the urine, a valve adapted to release the captured urine from the urine collection chamber, and a source of flush water to clean the urine collection chamber.

Abstract: A toilet for measuring excreta is disclosed. The toilet is adapted to measure the amount of excreta received by the bowl and then the flush water. A pressure sensor is configured to monitor the pressure exerted by the flush water and any excreta contained therein. Data from monitoring the pressure of the flush water and excreta therein is used to determine the weight or volume of the excreta received by the bowl. This toilet can provide data which may be used to analyze how the volume of flush water changed due to excreta deposit. A volume change feature can be associated with a urination event and the data associated with the event can be used to determine a urine characteristic of the event.

Abstract: A symptomatic tremor detection system is disclosed. The system includes a seat sensor to measure at least a portion of weight from a user on a seat and a foot sensor to measure at least a portion of weight from the user on a foot support while the user is on the seat and supporting a foot with a foot support. The data from the seat sensor and the force sensor is used to identify a temporary weight changes in the data which correlate with the manifestation of symptomatic tremors. An additional, or tertiary, force sensor may also be used with the system to provide additional data relevant to the detection of symptomatic tremors.

Abstract: An analytical toilet comprising a bowl for receiving excreta from a user, a urine collection chamber for receiving urine from the bowl, a sensor for detecting properties of the urine, a valve adapted to release the captured urine from the urine collection chamber, and a source of flush water to clean the urine collection chamber.

Abstract: A system for distinguishing a type of excreta deposited in a toilet is disclosed. The system includes a toilet and a processor. The toilet has a bowl adapted to receive multiple types of excreta from a user and a sensor which monitors the volume of excreta deposited in the toilet. The processor compares excreta volume data derived from the sensor to a database comprising excreta-type volume data and associates a time segment from the excreta volume data as representing an excreta-type. This system can provide data which may be used to determine the rate of excreta deposit into the toilet and associated those rates with excreta events types such as urination or defecation.

Abstract: We disclose an in-toilet urinalysis system which includes a system for collection urine and for analysis of urine components using aptamer technology. Urine collection system may dispense urine into cuvettes, channels, or other containers that include aptamers. The aptamers may detect target molecules in urine. The aptamers may measure urine analytes, detect excreted drugs or drug metabolites, or disease markers. Upon binding to the target molecule, the aptamers may produce a signal which a sensor in the toilet may detect. In some embodiments, the signal may be electrochemical, fluorescent, or colorimetric. The measurements obtained from analysis of the urine may be used to assess a user's health or diagnose disease. In some embodiments, the measurements are stored in a controller which may transmit the measurements to a healthcare provider for assessment.

Abstract: The medical toilet may include a seat, lid, and bowl as does a traditional toilet. It also includes one or more acoustic transducers. The acoustic transducers may be located on the seat where they may measure bone density in a user's pelvis or femur. The acoustic transducers may be located on the lid or on a belt which wraps around the user. These acoustic transducers may collect data relating to a user's heart, lungs, liver, bowel, or other internal organs. The medical toilet may include a handrail with an acoustic transducer which measures the bone density in the user's wrist, radius, or ulna. A controller associated with the medical toilet may store algorithms for analyzing the data collected by the acoustic transducers. The controller may perform machine learning to improve the analyses and may calculate trends in repeated measurements taken from the same user or a population of users.

Abstract: A system for providing a report on vascular health of a user is disclosed. The system includes a toilet with a bowl adapted to receive excreta from the user and a processor. The toilet includes a seat with weight and PPG sensors. BCG data is derived from the weight sensor data. PPG data is derived from the PPG sensor. The processor performs a comparison of the data from the weight sensor and the data from the PPG sensor and preexisting data in a database. The processor then generates a report on the user's vascular health based on the comparison.

Abstract: The medical toilet includes one or more sensors for measuring hardness of a soft tissue in contact with the sensor. The one or more sensors may be positioned on the toilet seat, toilet lid, or on a foot scale which extends from the base of the medical toilet. The sensors may include durometers, fluid-filled bubbles with pressure sensors on them, or an inflatable tube with pressure sensors on it. The measurements may be transmitted to a controller which may store and analyze the data. Changes in tissue hardness over time may be tracked and reported. The sensors may identify changes in the hardness of skin, adipose tissue, and muscle. These measurements may be useful to identify changes in skin thickness, body fat, muscle tone, tumors and other masses.

Abstract: The sensor platform array includes a plurality of sensors and one or more sensor platforms. Each sensor may be mounted on a sensor platform. The sensor platform may be mounted on a support panel. The support panel may be mounted on a toilet lid. The one or more sensor platforms may be extendable towards a user seated on the toilet. Each sensor may be independently extended so that it is positioned flush against a user's body. The sensor platform array may include bendable arms which reach around a user and place sensors on the ventral side of the user. The sensors may collect measurements which are relevant to the user's health and well-being. In some embodiments, the sensors may be removable and replaceable so that different sensors may be added according to a user's individual needs.

Abstract: The sensor platform array includes a plurality of sensors and one or more sensor platforms. Each sensor may be mounted on a sensor platform. The sensor platform may be mounted on a support panel. The support panel may be mounted on a toilet lid. The one or more sensor platforms may be extendable towards a user seated on the toilet. Each sensor may be independently extended so that it is positioned flush against a user's body. The sensor platform array may include bendable arms which reach around a user and place sensors on the ventral side of the user. The sensors may collect measurements which are relevant to the user's health and well-being. In some embodiments, the sensors may be removable and replaceable so that different sensors may be added according to a user's individual needs.

Abstract: We disclose a method of tagging nutritional or drug compositions using chemical entities which are known to be safely consumed and which are detectable using known techniques, including near IR spectroscopy. The chemical entities used as tags may be detected in easily obtainable biological samples, including urine and feces. The biological sample may be deposited into a medical toilet which may analyze the biological sample using an analytical device associated with the medical toilet. The tag may be identified and quantified to then identify and quantify the nutritional or drug composition the subject consumed along with the tag. This system may be used to track the source of a food or drug, confirm compliance to a prescribed diet or drug treatment, confirm drug consumption in clinical trials, identify the source of contaminated food, and identify the food substances used to produce food products.

Abstract: The bidet system may include multiple seat scales which may float between the toilet bowl rim and the toilet seat. These seat scales may collect measurements which are transmitted to a controller. The controller may include instructions to calculate a user's center of mass based on the measurements and to identify the position of the user's anus based on the center of mass. The controller may then transmit instructions to a bidet wand directing direct the bidet wand to a position which aims a cleansing fluid spray toward the user's anus. A camera which collects images of the user's anal and urogenital region may also be included in the bidet system. The camera may transmit obfuscated images to the controller to identify other areas of the user's anatomy in need of cleansing. The controller may direct the bidet wand to aim a cleansing fluid spray toward these areas.

Abstract: We disclose a method of using taggants to assess how and to what extent a drug in a drug composition that a user has consumed has decayed in response to storage conditions and time. The taggants may decay in response to environmental conditions which cause different drugs to lose their efficacy. These environmental conditions may include light, temperature, oxidation, and age. The taggants may be detected in biological samples, including urine and feces. By identifying the taggants, the drug composition and other information relating to the drug may be identified. Additionally, quantification of the different taggants may be used to determine whether the drug in the drug composition has been exposed to environmental conditions which may reduce its efficacy.